Investigating the molecular basis of major depressive disorder etiology: A functional convergent genetic approach

Annals of the New York Academy of Sciences

Volumn 1148, Issue , 2008, Pages 42-56

  Jabbi, Mbemba ^a,b   Korf, Jaap ^a   Ormel, Johan ^a   Kema, Ido P ^a   Den Boer, Johan A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Convergent; Genes; MDD; Monoamines; Stress

Indexed keywords

GLUCOCORTICOID; HYDROCORTISONE; MONOAMINE; NORADRENALIN; SEROTONIN;

5 HTT GENE; COMT GENE; CONFERENCE PAPER; EMOTION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL STRESS; EVOLUTIONARY ADAPTATION; GENE; GENE INTERACTION; GENE MAPPING; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MAOA GENE; NEUROCHEMISTRY; NONHUMAN; PHENOTYPE;

EID: 57649174631     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1410.018     Document Type: Conference Paper

References (112)

1. Fava, M. & K.S. Kendler. 2000. Major depressive disorder. Neuron 28 : 335 341.
2. Meyer-Lindenberg, A. & D.R. Weinberger. 2006. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat. Rev. Neurosci. 7 : 818 827.
3. Plotsky, P.M., M.J. Owens & C.B. Nemeroff. 1998. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr. Clin. North Am. 21 : 293 307.
4. Charney, D.S. 2004. Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am. J. Psychiatry 161 : 195 216.
5. Sullivan, P.F., M.C. Neale & K.S. Kendler. 2000. Genetic epidemiology of major depression: review and meta-analysis. Am. J. Psychiatry 157 : 1552 1562.
6. Caspi, A. & T.E. Moffitt. 2006. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat. Rev. Neurosci. 7 : 583 590.
7. Blazer, D.G. et al. 1994. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am. J. Psychiatry 151 : 979 986.
8. Kessler, R.C. et al. 1994. Sex and depression in the national comorbidity survey. II: cohort effects. J. Affect. Disord. 30 : 15 26.
9. Kessler, R.C. 1997. The effects of stressful life events on depression. Annu. Rev. Psychol. 48 : 191 214.
10. Kessler, R.C. et al. 1997. Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. J. Affect. Disord. 45 : 19 30.
11. Berton, O. & E.J. Nestler. 2006. New approaches to antidepressant drug discovery: beyond monoamines. Nat. Rev. Neurosci. 7 : 137 151.
12. Tipton, K.F. et al. 2004. Monoamine oxidases: certainties and uncertainties. Curr. Med. Chem. 11 : 1965 1982.
13. Youdim, M.B., D. Edmondson & K.F. Tipton. 2006. The therapeutic potential of monoamine oxidase inhibitors. Nat. Rev. Neurosci. 7 : 295 309.
14. Shih, J.C. & K. Chen. 1999. MAO-A and -B gene knock-out mice exhibit distinctly different behavior. Neurobiology (Bp) 7 : 235 246.
15. Holmes, A. 2001. Targeted gene mutation approaches to the study of anxiety-like behavior in mice. Neurosci. Biobehav. Rev. 25 : 261 273.
16. Holmes, A. & A.R. Hariri. 2003. The serotonin transporter gene-linked polymorphism and negative emotionality: placing single gene effects in the context of genetic background and environment. Genes. Brain Behav. 2 : 332 335.
17. Holmes, A. et al. 2003. Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes. Brain Behav. 2 : 365 380.
18. Holmes, A., D.L. Murphy & J.N. Crawley. 2003. Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biol. Psychiatry 54 : 953 959.
19. Holmes, A. et al. 2003. Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology 28 : 2077 2088.
20. Li, Q. et al. 2004. Medial hypothalamic 5-hydroxytryptamine (5-HT)1A receptors regulate neuroendocrine responses to stress and exploratory locomotor activity: application of recombinant adenovirus containing 5-HT1A sequences. J. Neurosci. 24 : 10868 10877.
21. Lira, A. et al. 2003. Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol. Psychiatry 54 : 960 971.
22. Ren-Patterson, R.F. et al. 2005. Serotonergic-like progenitor cells propagated from neural stem cells in vitro: survival with SERT protein expression following implantation into brains of mice lacking SERT. FASEB J. 19 : 1537 1539.
23. Vizi, E.S. et al. 2003. A new short-acting non-depolarizing muscle relaxant (SZ1677) without cardiovascular side-effects. Acta Anaesthesiol. Scand. 47 : 291 300.
24. Kendler, K.S., J. Kuhn & C.A. Prescott. 2004. The interrelationship of neuroticism, sex, and stressful life events in the prediction of episodes of major depression. Am. J. Psychiatry 161 : 631 636.
25. Enoch, M.A. et al. 2003. Genetics of alcoholism using intermediate phenotypes. Alcohol. Clin. Exp. Res. 27 : 169 176.
26. Funke, B. et al. 2005. COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behav. Brain Funct. 1 : 19.
27. Karayiorgou, M. et al. 1999. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol. Psychiatry 45 : 1178 1189.
28. Maier, L.M. et al. 2005. No evidence of association or interaction between the IL4RA, IL4, and IL13 genes in type 1 diabetes. Am. J. Hum. Genet. 76 : 517 521.
29. Strauss, J. et al. 2004. Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 131 : 16 19.
30. Yu, Y.W. et al. 2005. Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response. Neuropsychopharmacology 30 : 1719 1723.
31. Zalsman, G. et al. 2005. Relationships between serotonin transporter promoter polymorphism, platelet serotonin transporter binding and clinical phenotype in suicidal and non-suicidal adolescent inpatients. J. Neural. Transm. 112 : 309 315.
32. Zalsman, G. et al. 2004. DRD4 receptor gene exon III polymorphism in inpatient suicidal adolescents. J. Neural. Transm. 111 : 1593 1603.
33. Cloninger, C.R., D.M. Svrakic & T.R. Przybeck. 1993. A psychobiological model of temperament and character. Arch. Gen. Psychiatry 50 : 975 990.
34. Buckholtz, J.W. et al. 2008. Genetic variation in MAOA modulates ventromedial prefrontal circuitry mediating individual differences in human personality. Mol. Psychiatry 13 : 313 324.
35. Kendler, K.S. 2005. "A gene for...": the nature of gene action in psychiatric disorders. Am. J. Psychiatry 162 : 1243 1252.
36. Kendler, K.S. 2005. Toward a philosophical structure for psychiatry. Am. J. Psychiatry 162 : 433 440.
37. Kendler, K.S. 2005. Psychiatric genetics: a methodologic critique. Am. J. Psychiatry 162 : 3 11.
38. Kendler, K.S. et al. 2005. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch. Gen. Psychiatry 62 : 529 535.
39. Lachman, H.M. et al. 1996. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6 : 243 250.
40. Lotta, T. et al. 1995. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34 : 4202 4210.
41. Hendriks, R.W. et al. 1992. An X chromosome inactivation assay based on differential methylation of a CpG island coupled to a VNTR polymorphism at the 5′ end of the monoamine oxidase A gene. Hum. Mol. Genet. 1 : 662.
42. Sabol, S.Z., S. Hu & D. Hamer. 1998. A functional polymorphism in the monoamine oxidase A gene promoter. Hum. Genet. 103 : 273 279.
43. Charmandari, E., C. Tsigos & G. Chrousos. 2005. Endocrinology of the stress response. Annu. Rev. Physiol. 67 : 259 284.
44. Heuser, I., A. Yassouridis & F. Holsboer. 1994. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J. Psychiatr. Res. 28 : 341 356.
45. Jabbi, M. et al. 2007. Catechol-o-methyltransferase polymorphism and susceptibility to major depressive disorder modulates psychological stress response. Psychiatr. Genet. 17 : 183 193.
46. Jabbi, M. et al. 2007. Convergent genetic modulation of the endocrine stress response involves polymorphic variations of 5-HTT, COMT and MAOA. Mol. Psychiatry 12 : 483 490.
47. Kendler, K.S. et al. 2005. Genetic and environmental influences on illicit drug use and tobacco use across birth cohorts. Psychol. Med. 35 : 1349 1356.
48. Froger, N. et al. 2004. Neurochemical and behavioral alterations in glucocorticoid receptor-impaired transgenic mice after chronic mild stress. J. Neurosci. 24 : 2787 2796.
49. Lanfumey, L. et al. 2000. 5-HT-HPA interactions in two models of transgenic mice relevant to major depression. Neurochem. Res. 25 : 1199 1206.
50. Lindley, S.E., X. She & A.F. Schatzberg. 2005. Monoamine oxidase and catechol-o-methyltransferase enzyme activity and gene expression in response to sustained glucocorticoids. Psychoneuroendocrinology 30 : 785 790.
51. Oswald, L.M. et al. 2004. Catechol-O-methyltransferase polymorphism alters hypothalamic-pituitary-adrenal axis responses to naloxone: a preliminary report. Biol. Psychiatry 55 : 102 105.
52. Reul, J.M. et al. 1994. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology 60 : 509 519.
53. Caspi, A. et al. 2003. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301 : 386 389.
54. Craddock, N., M.J. Owen & M.C. O'Donovan. 2006. The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons. Mol. Psychiatry 11 : 446 458.
55. Li, D., Y. Duan & L. He. 2006. Association study of serotonin 2A receptor (5-HT2A) gene with schizophrenia and suicidal behavior using systematic meta-analysis. Biochem. Biophys. Res. Commun. 340 : 1006 1015.
56. Massat, I. et al. 2005. Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study. Mol. Psychiatry 10 : 598 605.
57. Munafo, M.R. & J. Flint. 2004. Meta-analysis of genetic association studies. Trends Genet. 20 : 439 444.
58. Preisig, M. et al. 2000. Association between bipolar disorder and monoamine oxidase A gene polymorphisms: results of a multicenter study. Am. J. Psychiatry 157 : 948 955.
59. Savitz, J.B., C.L. Cupido & R.S. Ramesar. 2006. Trends in suicidology: personality as an endophenotype for molecular genetic investigations. PLoS Med. 3 : e107.
60. Schinka, J.A., E.A. Letsch & F.C. Crawford. 2002. DRD4 and novelty seeking: results of meta-analyses. Am. J. Med. Genet. 114 : 643 648.
61. Moffitt, T.E., A. Caspi & M. Rutter. 2005. Strategy for investigating interactions between measured genes and measured environments. Arch. Gen. Psychiatry 62 : 473 481.
62. Shors, T.J. 2006. Significant life events and the shape of memories to come: a hypothesis. Neurobiol Learn Mem. 85 : 103 115.
63. Smith, A.P. et al. 2006. Task and content modulate amygdala-hippocampal connectivity in emotional retrieval. Neuron 49 : 631 638.
64. Kendler, K.S., J. Myers & C.A. Prescott. 2005. Sex differences in the relationship between social support and risk for major depression: a longitudinal study of opposite-sex twin pairs. Am. J. Psychiatry 162 : 250 256.
65. Uhart, M. et al. 2006. Gender differences in hypothalamic-pituitary- adrenal (HPA) axis reactivity. Psychoneuroendocrinology 31 : 642 652.
66. Brown, G.W. & T. Harris. 1978. Social origins of depression: a reply. Psychol. Med. 8 : 577 588.
67. Ormel, J., A.J. Oldehinkel & E.I. Brilman. 2001. The interplay and etiological continuity of neuroticism, difficulties, and life events in the etiology of major and subsyndromal, first and recurrent depressive episodes in later life. Am. J. Psychiatry 158 : 885 891.
68. Uhart, M. et al. 2004. GABRA6 gene polymorphism and an attenuated stress response. Mol. Psychiatry 9 : 998 1006.
69. Rakvag, T.T. et al. 2005. The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain 116 : 73 78.
70. Ribeiro, S.C. et al. 2005. Interface of physical and emotional stress regulation through the endogenous opioid system and mu-opioid receptors. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 : 1264 1280.
71. Zubieta, J.K. et al. 2003. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299 : 1240 1243.
72. Goldberg, T.E. & D.R. Weinberger. 2004. Genes and the parsing of cognitive processes. Trends Cogn. Sci. 8 : 325 335.
73. Weinberger, D.R. et al. 2001. Prefrontal neurons and the genetics of schizophrenia. Biol. Psychiatry 50 : 825 844.
74. Smolka, M.N. et al. 2005. Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J. Neurosci. 25 : 836 842.
75. Wang, J. et al. 2005. Perfusion functional MRI reveals cerebral blood flow pattern under psychological stress. Proc. Natl. Acad. Sci. USA 102 : 17804 17809.
76. Simon, G.E. et al. 1999. An international study of the relation between somatic symptoms and depression. N. Engl. J. Med. 341 : 1329 1335.
77. Max, M.B. et al. 2006. A clinical genetic method to identify mechanisms by which pain causes depression and anxiety. Mol. Pain 2 : 14.
78. Craig, A.D. 2002. How do you feel? Interoception: the sense of the physiological condition of the body. Nat. Rev. Neurosci. 3 : 655 666.
79. Drolet, G. & S. Rivest. 2001. Corticotropin-releasing hormone and its receptors; an evaluation at the transcription level in vivo. Peptides 22 : 761 767.
80. Chong, R.Y. et al. 2006. The micro-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress. Neuropsychopharmacology 31 : 204 211.
81. Calogero, A.E. et al. 1988. Regulation of rat hypothalamic corticotropin-releasing hormone secretion in vitro: potential clinical implications. Adv. Exp. Med. Biol. 245 : 167 181.
82. Calogero, A.E. et al. 1988. Effect of cholinergic agonists and antagonists on rat hypothalamic corticotropin-releasing hormone secretion in vitro. Neuroendocrinology 47 : 303 308.
83. Calogero, A.E. et al. 1988. Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro. J. Clin. Invest. 82 : 839 846.
84. Kiss, A. & G. Aguilera. 1992. Participation of alpha 1-adrenergic receptors in the secretion of hypothalamic corticotropin-releasing hormone during stress. Neuroendocrinology 56 : 153 160.
85. Valentino, R.J., S.L. Foote & G. Aston-Jones. 1983. Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res. 270 : 363 367.
86. Calogero, A.E. et al. 1990. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology 126 : 1888 1894.
87. Fuller, R.W. & H.D. Snoddy. 1990. Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists. Neuroendocrinology 52 : 206 211.
88. Overton, J.M. & L.A. Fisher. 1989. Modulation of central nervous system actions of corticotropin-releasing factor by dynorphin-related peptides. Brain Res. 488 : 233 240.
89. Chrousos, G.P. & P.W. Gold. 1992. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267 : 1244 1252.
90. Habib, K.E., P.W. Gold & G.P. Chrousos. 2001. Neuroendocrinology of stress. Endocrinol. Metab. Clin. North. Am. 30 : 695 728 vii viii.
91. de Kloet, E.R., M. Joels & F. Holsboer. 2005. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 6 : 463 475.
92. Korte, S.M. et al. 2005. The Darwinian concept of stress: benefits of allostasis and costs of allostatic load and the trade-offs in health and disease. Neurosci. Biobehav. Rev. 29 : 3 38.
93. Bartels, M. et al. 2003. Heritability of daytime cortisol levels in children. Behav. Genet. 33 : 421 433.
94. Bartels, M. et al. 2003. Heritability of cortisol levels: review and simultaneous analysis of twin studies. Psychoneuroendocrinology 28 : 121 137.
95. Kim-Cohen, J. et al. 2006. MAOA, maltreatment, and gene-environment interaction predicting children's mental health: new evidence and a meta-analysis. Mol. Psychiatry 11 : 903 913.
96. Kreek, M.J. et al. 2005. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol. Rev. 57 : 1 26.
97. Meyer-Lindenberg, A. et al. 2006. Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc. Natl. Acad. Sci. USA 103 : 6269 6274.
98. Schmidt, L.G. et al. 2000. Different allele distribution of a regulatory MAOA gene promoter polymorphism in antisocial and anxious-depressive alcoholics. J. Neural. Transm. 107 : 681 689.
99. Aina, Y. & J.L. Susman. 2006. Understanding comorbidity with depression and anxiety disorders. J. Am. Osteopath. Assoc. 106 : S9 S14.
100. Lesch, K.P. 2004. Gene-environment interaction and the genetics of depression. J. Psychiatry Neurosci. 29 : 174 184.
101. Olincy, A., D.A. Young & R. Freedman. 1997. Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biol. Psychiatry 42 : 1 5.
102. Egan, M.F. et al. 2001. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. USA 98 : 6917 6922.
103. Palmatier, M.A. et al. 2004. COMT haplotypes suggest P2 promoter region relevance for schizophrenia. Mol. Psychiatry 9 : 859 870.
104. Heinz, A. et al. 2005. Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat. Neurosci. 8 : 20 21.
105. Pezawas, L. et al. 2005. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat. Neurosci. 8 : 828 834.
106. Meyer-Lindenberg, A. et al. 2005. Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype. Nat. Neurosci. 8 : 594 596.
107. Hariri, A.R. et al. 2002. Serotonin transporter genetic variation and the response of the human amygdala. Science 297 : 400 403.
108. Weiss, G.K. et al. 1994. The effect of two different types of stress on locus coeruleus alpha-2 receptor binding. Brain Res. Bull. 33 : 219 221.
109. Wong, M.L. et al. 2000. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc. Natl. Acad. Sci. USA 97 : 325 330.
110. Segman, R.H. et al. 2005. Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors. Mol. Psychiatry 10 : 500 513, 425.
111. Wong, M.L. & J. Licinio. 2005. Peripheral is central to the question. Mol. Psychiatry 10 : 421 422.
112. Weiss, K.M. & J.D. Terwilliger. 2000. How many diseases does it take to map a gene with SNPs? Nat. Genet. 26 : 151 157.